Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti‐TNF and anti‐ interleukin‐17 failures

Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting

(2021) S. Ribero et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review

(2020) T. Montero-Vilchez et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Tildrakizumab in the treatment of moderate‐to‐severe hidradenitis suppurativa

(2020) Yonatan Kok et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Aetiology and pathogenesis of hidradenitis suppurativa

(2020) K. Wolk et al.   BRITISH JOURNAL OF DERMATOLOGY

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after anti‐TNF failure

(2020) E. Marques et al.   BRITISH JOURNAL OF DERMATOLOGY

Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa

(2019) Christos C. Zouboulis et al.   DERMATOLOGY

Guselkumab in the Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review

(2018) Rachel G. Casseres et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY